Your session is about to expire
← Back to Search
Ablation System
St. Jude Medical Cardiac Ablation System for Atrial Fibrillation (IRASE-AF Trial)
N/A
Waitlist Available
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this study is to test the safety and effectiveness of an Irrigated Ablation System for the treatment of symptomatic paroxysmal atrial fibrillation.
Eligible Conditions
- Atrial Fibrillation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of Adverse Events Included in the Pre-specified Composite
Secondary study objectives
Early Onset (Within 90 Days) of SAE/Non-serious AEs and Late Onset (After 90 Days) SAEs
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: St. Jude Medical Cardiac Ablation SystemExperimental Treatment1 Intervention
Group II: FDA approved Open Irrigated Radio Frequency Ablation SystemActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SJM Irrigated Cardiac Ablation System
2010
N/A
~330
Find a Location
Who is running the clinical trial?
Abbott Medical DevicesLead Sponsor
652 Previous Clinical Trials
416,513 Total Patients Enrolled
77 Trials studying Atrial Fibrillation
32,191 Patients Enrolled for Atrial Fibrillation
Share this study with friends
Copy Link
Messenger